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The 24-h urine protein-to-creatinine ratio is the gold standard
in evaluating proteinuria in lupus nephritis; however, the
urine collection is inconvenient to the patient. Random spot
urine protein-to-creatinine ratios, although convenient, have
poor agreement with the 24-h ratios in these patients.
Here, we sought to define a timed collection interval
providing accurate and precise data and patient
convenience. Urine from 41 patients, in 2 medical centers,
with biopsy-proven lupus nephritis was collected at 6-h
intervals for 24h. The protein-to-creatinine ratio of each
short collection was then compared with that of a 24-h
collection made by combining the 6-h samples. A first
morning void and spot urine samples were collected before
and after the 24-h collection, respectively. There was
significant diurnal variation with peak proteinuria at 6–12h
and nadir at 18–24h. Each 6-h collection showed excellent
correlation and concordance with the 24-h protein-to-
creatinine ratio, but the 12–24-h interval had the best
agreement. In contrast to the random spot urines, the first
morning void also had excellent correlation and
concordance, but underestimated the 24-h protein-to-
creatinine ratio. Our study shows that a 12-h overnight urine
collection is the best surrogate, with excellent agreement
with the 24-h protein-to-creatinine ratio, and it is convenient
for patients. There was little variability between centers, an
important feature for clinical trials.
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The accurate evaluation of proteinuria is critical to the
clinical management of systemic lupus erythematosus (SLE)
nephritis, because it is currently the most important
biomarker of disease activity and renal prognosis available.1–3
Furthermore, proteinuria is often a primary, secondary, or
surrogate end point in clinical trials of new therapies for
lupus nephritis (LN), and therefore must be measured with
precision.4 There has been considerable discussion regarding
the best way to measure daily urinary excretion of protein
in these patients, other than 24-h urine collections. If done
correctly, the 24-h collection is the best measure of
proteinuria. However, these collections are cumbersome for
patients and, therefore, prone to under and over collection,
compromising accuracy. Such collection problems can be
mitigated to some extent by using the protein/creatinine
(P/C) ratio of the 24-h specimen, hence many consider it the
gold standard for proteinuria assessment.4,5 Nonetheless,
collection of 24-h urine samples is still a burden if they need
to be collected frequently over the course of clinical care, and
are often not feasible for the extensive serial follow-up
required during clinical trials. Acknowledging the problems
associated with 24-h collections, validated instruments of
lupus activity base the diagnosis of renal flare on urine
dipstick measurements.6,7 Alternatively, random spot urine
P/C have been used for some time as an accurate
representation of the 24-h urine collection.8 Unfortunately,
both dipstick assessment of proteinuria and random spot
urine P/C ratios are inadequate measures of proteinuria.9–11
The P/C ratio of an intended 24-h urine collection that is
50% complete is accurate, but daytime 12-h collections may
also be difficult.11 Therefore, this investigation examined
shorter-timed urine collection intervals for agreement with
24-h specimens.
RESULTS
A total of 41 patients were enrolled. The majority were
women (80%), with about equal numbers of African-
Americans (46%) and Caucasians (42%) (Table 1). The age
(mean 36.1years, range 23–56 years) was typical for a SLE
population. In total, 15 patients had an acute flare of their
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renal disease within the previous 3 months. On the basis of
World Health Organization classification of LN, 2.7% of
patients had class I LN, 13.5% had class III, 37.8% had class
IV, 18.9% had class V, 16.2% had class IIIþV, 8.1% had class
IVþV, and 2.7% had class VI. The majority of the patients
were treated with prednisone (76%), mycophenolate mofetil
(73%), angiotensin-converting enzyme inhibitors and/or
angiotensin receptor blockers (66%), and hydroxychloroquine
(59%). Four of the patients who were not on mycophenolate
mofetil were on azathioprine. The mean (range) prednisone
and mycophenolate doses in those who were taking these
medications were 16.7 mg (3.25–60 mg) and 2141 mg
(500–3000 mg), respectively. The mean systolic blood pressure
and diastolic blood pressure were 130 and 81 mm Hg,
respectively. A total of 18 patients were hypertensive at the
clinic visit most proximal to the urine collection.
Urine was collected from these patients according to the
algorithm outlined in Figure 1. The 24-h urine protein levels
covered a wide range (0.04–9.04 g protein per g creatinine)
with a mean of 1.41 g protein per g creatinine. In total, 16
patients had 24-h P/C ratios 41 g/g of which 6 patients had
P/C ratios 43 g/g. Of the 41 patients, only 13 (32%) had an
MDRD (modification of diet in renal disease)-estimated
glomerular filtration rate X90 ml/min per 1.73 m2. A total of
13 (32%) had an estimated glomerular filtration rate in the
60–89 ml/min per 1.73 m2 range. The remaining 15 (37%)
had an estimated glomerular filtration rate o60 ml/min
per 1.73 m2 at the time of their urine collections. On the
basis of the ratio of the measured (M) creatinine on the
24-h urine specimen to the expected (E) creatinine (M/E ratio
0.8–1.2 considered complete), 69% (29/41) of collections were
deemed complete, with 2.4% (1/41) under collections.
Proteinuria is known to vary over the course of the day. To
assess diurnal variation in protein excretion, the P/C ratio for
each interval urine collection was divided by the P/C ratio of
its corresponding 24-h collection, and the mean (±2 s.e.m.)
of this ratio was calculated (Figure 2). Peak protein excretion
occurred from mid-day through to late afternoon, and was
lowest after patients went to bed.
Owing to this diurnal variation, the timed interval that
had the best agreement with the 24-h urine was determined.
Agreement is comprised of three components: correlation,
concordance, and accuracy. Therefore, the correlation
coefficient and concordance coefficient of each interval P/C
ratio compared with the 24-h P/C ratio were calculated, and
are shown in Table 2. Accuracy was calculated by dividing the
interval P/C by the subjects’ corresponding 24-h P/C and
then determining the mean of the ratios for the particular
interval (Table 2). The closer this value was to 1, the more
accurate. Not unexpectedly, the longer collection intervals
(12 and 18 h) showed the best agreement with 24-h
proteinuria. Furthermore, the variability of the interval P/C
ratios diminished with the 12- and 18-h collections
(Figure 3). Each 6-h timed collection showed excellent
correlation with the 24-h P/C ratio (Table 2; Figure 4), but
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SP0
(1st am)
SP24
12–24 h
18–24 h
Figure 1 |Collection timeline for interval collections. Spot 0
(SP0) was first morning urine and spot 2 (SP24) was obtained after
the 24-h urine collection was completed. Note that for Hopkins
lupus cohort (HLC), SP24 was obtained as the second morning
void and for Ohio SLE Study (OSS), as a random spot collection.
SLE, systemic lupus erythematosus.
In
te
rv
a
l/2
4-
h 
P/
C 
ra
tio
1.4
1.2
1
0.8
0.6
0.4
0.2
0
Time interval (h)
*
SP0 0–6 6–12 12–18 18–24
Figure 2 |Diurnal variation of protein excretion. Interval
protein/creatinine (P/C) ratios were divided by their
corresponding 24-h P/C ratios for the indicated intervals. SP0
represents the first morning void. The middle bar represents the
mean ratio, and the top and bottom bars represent ±2 standard
errors of the mean. *Po0.001 versus 18–24-h interval.
Table 1 | Demographic and laboratory characteristics of 41
patients with history of lupus nephritis
Characteristic Value
Age in years, median (range) 34.4 (22.5–56.3)
Gender
Female 33 (80%)
Ethnicity
African American 19 (46%)
Caucasian 17 (42%)
Asian 5 (12%)
24-h protein-to-creatinine ratio (g/g)
Mean (±s.d.) 1.41 (±1.97)
Median (range) 0.51 (0.04–9.04)
Serum creatinine (mg/dl)
Mean (±s.d.) 1.26 (±0.63)
Median (range) 1.2 (0.6–3.8)
Estimated GFRa (ml/min per 1.73m2)
Mean (±s.d.) 74.2 (±31.3)
Median (range) 77.4 (13.7–151.2)
ACE inhibitor/ARB treatment 27 (66%)
Prednisone treatment 31 (76%)
Mycophenolate mofetil treatment 30 (73%)
Hydroxychloroquine treatment 24 (59%)
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; GFR,
glomerular filtration rate; s.d., standard deviation.
aGFR by the modification of diet in renal disease (MDRD) formula.
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compared with 12- and 18-h collections, they generally had
lower concordance coefficients and/or ratios of the means
that were farther from the ideal 1. The 0–6-h interval seemed
to have the best combination of correlation, concordance,
and accuracy.
With respect to untimed collections, the random spot
urine sample SP24 showed very poor agreement with the
24-h P/C ratio (Table 2). Interestingly SP0 showed a
correlation coefficient of 0.98 and concordance correlation
coefficient of 0.95, but underestimated the 24-h P/C (ratio of
the means¼ 0.78). The mean SP0 P/C ratio was significantly
different than the mean 0–6-h P/C ratio (Po0.01).
Owing to the different measurement assays used at the two
participating institutions, patients were stratified based on
institution to exclude a center effect (Table 2). The most
significant difference was seen in the SP24 spot collection.
This was likely accounted for by differences in timing of this
spot collection. As described in Methods, SP24 was a random
urine in Ohio SLE Study (OSS) patients, but was the second
morning void in Hopkins lupus cohort (HLC) patients. Of
the 6-h collections, only the 0–6-h time interval showed a
significant difference between the institutions (Table 2). This
difference can largely be accounted for by one extreme value
(24-h P/C ratio¼ 3.82) in the OSS cohort. Without this
Table 2 | Agreement of timed intervals with the 24-h P/C
Interval Pearson (r) Concordance correlation coefficient (lower 95% CI) Mean (Interval/24-h P/C) (95% CI)
Spot 0 (SP0)—1st am void (SP0) (n=40) 0.976 0.949 (0.929) 0.89 (0.80–0.98)
HLC (n=24) 0.979 0.947 (0.911) 0.82 (0.74–0.90)
OSS (n=16) 0.939 0.922 (0.851) 1.00 (0.80–1.20)
Spot 24 (SP24)—day 2 (SP24) (n=39) 0.923 0.892 (0.841) 0.91 (0.74–1.08)
HLC (n=24)a 0.957 0.930 (0.874) 0.77 (0.67–0.88)
OSS (n=15)b 0.444 0.328 (0.037) 1.13 (0.70–1.55)
0–6 h 0.947 0.944 (0.916) 0.98 (0.89–1.08)
HLC 0.957 0.951 (0.915) 0.94 (0.85–1.03)
OSS 0.796 0.764 (0.566) 1.05 (0.83–1.27)
6–12 h 0.988 0.950 (0.934) 1.19 (1.12–1.27)
HLC 0.989 0.942 (0.909) 1.21 (1.14–1.29)
OSS 0.986 0.976 (0.952) 1.16 (1.00–1.32)
12–18 h 0.943 0.937 (0.905) 1.17 (1.06–1.27)
HLC 0.952 0.949 (0.908) 1.20 (1.07–1.32)
OSS (n=15) 0.972 0.841 (0.764) 1.12 (0.92–1.31)
18–24 h 0.990 0.917 (0.893) 0.83 (0.74–0.91)
HLC 0.989 0.905 (0.853) 0.78 (0.68–0.88)
OSS 0.989 0.937 (0.892) 0.90 (0.75–1.06)
0–12 h 0.979 0.965 (0.951) 1.07 (1.01–1.13)
HLC 0.979 0.960 (0.935) 1.06 (1.00–1.12)
OSS 0.980 0.977 (0.952) 1.09 (0.96–1.22)
12–24 h 0.980 0.971 (0.955) 0.98 (0.91–1.05)
HLC 0.979 0.966 (0.942) 0.97 (0.90–1.03)
OSS 0.992 0.986 (0.976) 1.00 (0.84–1.16)
0–18 h 0.997 0.988 (0.983) 1.08 (1.04–1.12)
HLC 0.996 0.986 (0.978) 1.10 (1.05–1.15)
OSS 0.998 0.986 (0.977) 1.05 (0.97–1.12)
CI, confidence interval; HLC, Hopkins lupus cohort; OSS, Ohio SLE Study; P/C, protein/creatinine; SLE, systemic lupus erythematosus.
aSpot urine collected as first urine after completing 24-h collection.
bSpot urine collected randomly after completion of 24-h collection.
Collections stratified by center: HLC (n=25) and OSS (n=16).
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Figure 3 |Variability of interval protein/creatinine (P/C) ratio
declines as the duration of the interval approaches 24 h. Box-
and-whisker plots of individual interval P/C ratios divided by their
corresponding 24-h P/C ratio. Boxes represent the interquartile
range. Whisker lengths represent up to 1.5 times the interquartile
range. Outliers beyond the whiskers are shown with open circles.
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value, the correlation coefficient (r) increased from 0.796 to
0.942 and the rc from 0.764 to 0.867. Importantly, for the 12-
and 18-h intervals, little center effect was observed (Table 2).
A separate analysis was performed after removing the
most extreme data point (24-h P/C of 9.04 g/g in the HLC
cohort) to assess the influence of this potential outlier on the
findings. There was only a small effect (data not shown) of its
removal on concordance, correlation, and ratio of the means.
The largest effect was seen in the 0–6-h time interval in which
the overall r dropped from 0.947 to 0.923 and the rc from
0.944 to 0.919. Within the HLC 0–6-h time interval, r fell
from 0.957 to 0.935 and rc from 0.951 to 0.933.
We next determined whether an average of SP0 and SP24
would provide improved agreement for spot urines. This was
done because collecting a first and second morning void
would be easy to do and, therefore, potentially clinically
useful. Averaging the SP0 and SP24 in the HLC (first and
second morning voids) improved the concordance and
correlation with the 24-h P/C, but did not change the ratio
of means (rc¼ 0.957, r¼ 0.991, ratio of the means¼ 0.80).
It is conceivable that the accuracy of SP0 could be affected
by level of kidney function, because patients with impaired
kidney function often have nocturia due to an inability to
concentrate their urine. The difference in the mean P/C ratio
of SP0 and the 24-h collection, however, showed no
relationship to serum creatinine or estimated glomerular
filtration rate (data not shown).
DISCUSSION
The goal of this investigation was to identify a short-interval,
timed urine collection that provides an accurate and precise
reflection of 24-h proteinuria in patients with SLE nephritis,
and can be readily applied to both routine clinical care and
clinical trial design. It was found that the P/C ratio of 6-h
timed collections correlated well with the P/C ratio of 24-h
collections and showed reasonably good concordance.
However, they were not sufficiently accurate, and the best
6-h interval (0–6 h) showed a large center effect. The
12-h interval collections had excellent agreement with 24-h
collections and displayed no center effect. Therefore, a 12-h
interval was considered the shortest time interval that could
be used as a substitute for a 24-h collection. More specifically,
the 12-h overnight interval seems to be optimal on the basis
of its strong agreement and ease of collection. We suggest that
a 12-h overnight urine collection is manageable by most
patients, as it does not require collection during working
hours, is sufficiently easy so it can be obtained frequently, and
is logistically feasible for clinical trials. The data also showed,
not unexpectedly, that the longer the duration of collection
the closer the approximation to a true 24-h urine.
Importantly, this study re-demonstrated that random spot
P/C ratios show poor correlation and poor agreement with
24-h urine P/C ratios. The true random spot urines (OSS
cohort, SP24, n¼ 15) showed a correlation coefficient of 0.44
and a concordance correlation coefficient of 0.33. This is not
unexpected, as the data represent P/C ratios from different
times of the day, which are known to have up to threefold
variation relative to the 24-h P/C ratios even under controlled
conditions.12 This diurnal variation is further shown in this
study, in which the 6–12-h interval had a 1.44-times greater
mean P/C ratio relative to the 18–24-h time interval.
Interestingly, the first morning void spot urine (SP0) from
both cohorts, and SP24 (n¼ 24) from the HLC (a second
morning void spot urine), had correlation and concordance
correlation coefficients of 40.95 and 0.91, respectively. It
must be emphasized that, although these are spot urine
collections, they are not random collections, because they are
the first or second voids of the day. These data suggest that
consistency in the timing of collection may improve the
agreement of spot with 24-h P/C ratios. In this regard, the
first morning spot urine may be particularly relevant, because
it is easy to collect, and probably represents as uniform an
achieved condition as possible among outpatients. The data
from the HLC SP24 urines are provocative, but difficult to
generalize, because the number of urine samples is small
(n¼ 24) and obtained from only one cohort. Finally, it
should be pointed out that all of the spot urines, whether
random or non-random, underestimated the 24-h P/C ratio.
In conclusion, short-interval timed urine collections can be
used as a surrogate for 24-h collections for proteinuria to
increase patient compliance and improve accuracy of the
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Figure 4 |Correlation of 6- and 12-h protein/creatinine (P/C)
ratio with 24-h P/C ratio. The dashed line represents the line
of perfect concordance (451 line); the solid line is the best-fit
regression.
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results. On the basis of our current data, we recommend a 12-h
overnight collection, which is likely to be easier for most
patients, will provide a more accurate collection than 6-h
intervals, and seems to be comparable between centers, which
will be important for clinical trials. Random spot P/C
measurements should not be used to follow or make manage-
ment decisions for patients with LN. Although a first-void
morning spot sample may underestimate the 24-h P/C, this
non-random spot collection may be useful as a screening test in
detecting lupus renal flares or following response to treatment.
MATERIALS AND METHODS
Patients with a history of biopsy-proven LN, and a spot urine P/C
ratio 40.2 or 24-h urine protein 40.15 g, were eligible for the
study. This study was reviewed and approved by the Johns Hopkins
University School of Medicine and Ohio State University institu-
tional review boards. All patients gave a written informed consent.
The study population of 41 patients included 25 patients enrolled in
the HLC, started in 1987 to study the outcome of SLE,13 and 16
from the OSS, a prospective longitudinal study of the natural history
of lupus flare since 2001.14
All patients submitted 24-h urine collections (Figure 1). The
24-h urine samples were collected at intervals of 0–6, 6–12, 12–18,
and 18–24 h. The first morning void was collected immediately
before the timed intervals began (time 0) and was designated spot 0
(SP0). Time 24 was defined as including the first morning void at
the end of the 24-h collection. All patients were asked to submit a
second spot urine (SP24) after the 24-h collection was completed.
For patients in the OSS cohort, this was the random spot urine,
collected at the clinic when the patients returned their urine
containers. For the HLC, SP24 was always the first void after
completing the 24-h collection, and was often done at home before
returning the urine containers. This difference in SP24 collection
was unintentional and based on a different interpretation of the
prospective protocol at the two institutions.
Urine creatinine and protein measurements were carried out
in the hospital’s clinical laboratories. For the OSS, the Beckman
Coulter Synchron LX system (Beckman Coulter, Fullerton, CA) was
utilized, using a pyrogallol red method for protein and modified
Jaffe rate for creatinine measurement. For the HLC, urine
protein and creatinine were measured with the Hitachi 917 system
(Roche Diagnostics, Indianapolis, IN, USA), using a benzethonium
chloride method and Roche Creatinine plus (Roche Diagnostics,
Indianapolis, IN, USA) (enzymatic assay), respectively. The different
assays used at the two institutions are likely to have minimal
influence in pooling the data, as the different methods have been
shown to correlate highly in the studied ranges.15,16 Urine volume
was also measured precisely to allow accurate calculation of P/C
ratios for each of the cumulative time intervals shown in Figure 1.
Analyses
Urine was collected over 24 h. P/C ratios of aliquots obtained from
the different time intervals of the 24-h collection were compared
with the total P/C ratio of the entire 24-h collection. The strength of
the linear correlation between interval and 24-h P/C ratios was
determined by calculating the Pearson correlation coefficient (r).
The degree of deviation from the line of identity between interval
P/C ratios and 24-h P/C ratios (that is, the 451 line) was measured
by the concordance correlation coefficient (rc), which assesses both
precision (variation in standard deviations) and accuracy (variation
in means). Mixed effects analysis was used to estimate the P/C ratio
across time intervals to assess for diurnal variation. Completeness
of the 24-h urine protein samples was assessed by comparing the
total creatinine in the sample with the predicted creatinine
(22(age/9)* kg in women and 28(age/6)* kg in men).17 Collec-
tions were considered accurate if measured/expected ratios were
between 0.8 and 1.2. Analyses were performed using Stata version 8
(College Station, TX, USA) and SAS version 9.1.3 (SAS Institute,
Cary, NC, USA). All reported P-values are two-sided and
significance was set at Po0.05.
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